Astera Labs (NASDAQ:ALAB) Stock Jumps 6.8% - Should You Buy?

Key Points

• Astera Labs shares rose 6.8% to $230.91, with the article noting that a broader technology-stock rally may have supported the move.
• The company beat quarterly expectations, reporting EPS of $1.32 versus $1.19 expected and revenue of $584.9 million, up 153.6% year over year.
• Analysts overall rate the stock a “Moderate Buy,” with an average price target of $320.85, though views vary and Northland cut its FY2027 EPS forecast.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price was up 6.8% during trading on Wednesday. The company traded as high as $237.76 and last traded at $230.91. 3,966,352 shares changed hands during mid-day trading, a decline of 23% from the average daily volume of 5,153,752 shares. The stock had previously closed at $216.18.

Top Astera Labs Stories

Investors following ALAB have been watching these stories:

• Positive Sentiment: ALAB recently rallied amid a broader technology-stock surge, suggesting sector momentum helped support the shares; that move was not specific to company news. Astera Labs rallies on tech stock surge
• Neutral Sentiment: The company will participate in the BMO Technology and Innovation Leaders Conference on Nov. 12. The appearance may provide investor updates, but no new business announcement was included. Conference announcement
• Negative Sentiment: Northland cut its FY2027 EPS forecast to $4.79 from $5.43 and lowered estimates for Q2–Q4 2027, partially offsetting its higher 2026 projections. MarketBeat report

Analyst Upgrades and Downgrades

Several research firms have weighed in on ALAB. Northland Securities raised shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a research note on Wednesday, November 4th. Morgan Stanley raised their target price on Astera Labs from $382.00 to $389.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 4th. Citigroup cut Astera Labs from a "buy" rating to a "hold" rating in a research report on Friday, October 9th. Susquehanna lowered their price target on Astera Labs from $310.00 to $258.00 and set a "neutral" rating on the stock in a report on Wednesday, November 4th. Finally, BMO Capital Markets initiated coverage on Astera Labs in a research report on Thursday, November 5th. They set an "outperform" rating and a $375.00 price target on the stock. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $320.85.

Astera Labs Stock Performance

The business's 50 day simple moving average is $297.39 and its 200-day simple moving average is $256.20. The company has a market cap of $40.36 billion, a price-to-earnings ratio of 92.00 and a beta of 3.86.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The business had revenue of $584.90 million for the quarter, compared to analysts' expectations of $550.78 million. During the same period in the previous year, the company posted $0.49 EPS. Astera Labs's revenue was up 153.6% on a year-over-year basis. Research analysts expect that Astera Labs, Inc. will post 2.99 earnings per share for the current year.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 90,630 shares of the firm's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares of the company's stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares of the company's stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 408,558 shares of company stock worth $126,050,884. Insiders own 10.40% of the company's stock.

Institutional Trading of Astera Labs

A number of institutional investors have recently added to or reduced their stakes in the business. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs during the 2nd quarter worth $25,000. GK Wealth Management LLC acquired a new stake in shares of Astera Labs in the 3rd quarter valued at $29,000. Archer Investment Corp bought a new stake in Astera Labs in the second quarter worth $30,000. Signature Equity Partners LLC boosted its holdings in Astera Labs by 1,680.0% in the third quarter. Signature Equity Partners LLC now owns 89 shares of the company's stock worth $32,000 after purchasing an additional 84 shares in the last quarter. Finally, Transamerica Financial Advisors LLC bought a new stake in Astera Labs in the second quarter worth $35,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company's portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.